Grimes & Company’s Outlook Therapeutics OTLK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-500
| Closed | -$3.94K | – | 354 |
|
|
2023
Q4 | $3.94K | Hold |
500
| – | – | ﹤0.01% | 331 |
|
|
2023
Q3 | $2.21K | Hold |
500
| – | – | ﹤0.01% | 310 |
|
|
2023
Q2 | $17.4K | Hold |
500
| – | – | ﹤0.01% | 311 |
|
|
2023
Q1 | $10.9K | Hold |
500
| – | – | ﹤0.01% | 301 |
|
|
2022
Q4 | $10.8K | Hold |
500
| – | – | ﹤0.01% | 294 |
|
|
2022
Q3 | $12K | Hold |
500
| – | – | ﹤0.01% | 270 |
|
|
2022
Q2 | $10K | Buy |
+500
| New | +$10K | ﹤0.01% | 273 |
|